This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Fondation Imagine - Institut Des Maladies Genetiques, National Institute of Health and Medical Research. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 331 
1 out of 4 
1 out of 1,853 
Years Active: 2024
Title: The Innovative Journey of Corinne De Chappedelaine
Introduction
Corinne De Chappedelaine is a notable inventor based in Paris, France, recognized for her contributions to the field of cell therapy. With a focused expertise in generating T-cell progenitors, she has made significant advancements in medical science through her patented methodologies.
Latest Patents
De Chappedelaine holds a patent for a "Method for Generating T-cell Progenitors." This invention encompasses an innovative in vitro technique that involves exposing CD34+ cells to a medium containing a Notch ligand. This ligand is derived from a soluble domain of the Delta-like ligand 4, which is bound to an Fc region of a protein IgG. Additionally, the method incorporates a fragment of fibronectin featuring the motifs RGDS and CS-1, along with a heparin-binding domain. This patent reflects her commitment to advancing therapeutic options in the realm of cell therapy.
Career Highlights
Throughout her career, Corinne De Chappedelaine has lent her expertise to esteemed institutions, including Assistance Publique - Hôpitaux de Paris and Fondation Imagine - Institut des Maladies Génétiques. These organizations have provided her with platforms to further her research and collaborate on various scientific projects, establishing her as a key figure in her field.
Collaborations
In her professional journey, De Chappedelaine has collaborated with notable colleagues, including Marina Cavazzana and Isabelle André. These collaborations have likely enriched her research endeavors and contributed to her innovative approaches to cell therapy.
Conclusion
Corinne De Chappedelaine's inventive work in developing methods for T-cell progenitors marks her as a significant contributor to the field of biotechnology. Her patent reflects a blend of innovative thought and practical application that has the potential to enhance medical practices in cell therapy, paving the way for future advancements in the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile